Objective
Post weaning multisystemic wasting syndrome (PMWS) is an emerging disease of pigs, first recognised in 1996,caused presumably by the porcine circovirus type 2 (PCV 2). The disease is spreading rapidly in several European countries affected and is becoming a primary cause of economical loss. The main objectives of the project areL%(i) to obtain basis knowledge of the pathogenesis, epidemiology, and immunopathology of PCV infection and PWMS,
(ii) to develop tools for diagnosis of the infection,
(iii) to identify proper vaccines prototypes by using conventional and DNA-recombinant technology,
(iv) to evaluate the possible risk of PCV for humans, and
(v) to develop tools and criteria for assure quality and control of porcine reagent currently used in pig industry in respect to PCV. The design of prototype vaccines is a major milestone in the project.
Specific laboratorial techniques (isolation and growth of virus, in situ hybridization immunohistochemestry, immunoperoxidase monolayer assay, protein ELISA, PCR, Taqman, apoptosis test...) have been developed. Characterization of the natural PCV2 associated disease have been done by epidemiological, immunological, molecular biology and apoptosis studies. Moreover, a large epidemiological survey of risk factors for PMWS was carried out in 159 French and 62 Spanish (data analyses unfinished) farms with different production systems. Research focused on vaccine prototype against PCV infection and immunoprotection studies using these prototypes has prepared the way for future development in this field.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences data science
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences public health epidemiology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- natural sciences biological sciences molecular biology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
08193 BELLATERRA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.